These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
429 related articles for article (PubMed ID: 25409738)
1. HALT-IT--tranexamic acid for the treatment of gastrointestinal bleeding: study protocol for a randomised controlled trial. Roberts I; Coats T; Edwards P; Gilmore I; Jairath V; Ker K; Manno D; Shakur H; Stanworth S; Veitch A Trials; 2014 Nov; 15():450. PubMed ID: 25409738 [TBL] [Abstract][Full Text] [Related]
2. Tranexamic acid for acute gastrointestinal bleeding (the HALT-IT trial): statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial. Brenner A; Afolabi A; Ahmad SM; Arribas M; Chaudhri R; Coats T; Cuzick J; Gilmore I; Hawkey C; Jairath V; Javaid K; Kayani A; Mutti M; Nadeem MA; Shakur-Still H; Stanworth S; Veitch A; Roberts I; Trials; 2019 Jul; 20(1):467. PubMed ID: 31362765 [TBL] [Abstract][Full Text] [Related]
3. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial. HALT-IT Trial Collaborators Lancet; 2020 Jun; 395(10241):1927-1936. PubMed ID: 32563378 [TBL] [Abstract][Full Text] [Related]
4. A high-dose 24-hour tranexamic acid infusion for the treatment of significant gastrointestinal bleeding: HALT-IT RCT. Roberts I; Shakur-Still H; Afolabi A; Akere A; Arribas M; Austin E; Bal K; Bazeer N; Beaumont D; Brenner A; Carrington L; Chaudhri R; Coats T; Gilmore I; Halligan K; Hussain I; Jairath V; Javaid K; Kayani A; Lisman T; Mansukhani R; Miners A; Mutti M; Nadeem MA; Pollok R; Prowse D; Simmons J; Stanworth S; Veitch A; Williams J Health Technol Assess; 2021 Oct; 25(58):1-86. PubMed ID: 34663491 [TBL] [Abstract][Full Text] [Related]
6. The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Shakur H; Elbourne D; Gülmezoglu M; Alfirevic Z; Ronsmans C; Allen E; Roberts I Trials; 2010 Apr; 11():40. PubMed ID: 20398351 [TBL] [Abstract][Full Text] [Related]
7. CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial. Dewan Y; Komolafe EO; Mejía-Mantilla JH; Perel P; Roberts I; Shakur H; Trials; 2012 Jun; 13():87. PubMed ID: 22721545 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerance of early administration of tranexamic acid in patients with cirrhosis presenting with acute upper gastrointestinal bleeding: a study protocol for a multicentre, randomised, double-blind, placebo-controlled trial (the EXARHOSE study). Heidet M; Amathieu R; Audureau E; Augusto O; Nicolazo de Barmon V; Rialland A; Schmitz D; Pierrang F; Marty J; Chollet-Xémard C; Thirion O; Jacob L BMJ Open; 2018 Aug; 8(8):e021943. PubMed ID: 30099397 [TBL] [Abstract][Full Text] [Related]
9. Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT. Sprigg N; Flaherty K; Appleton JP; Al-Shahi Salman R; Bereczki D; Beridze M; Ciccone A; Collins R; Dineen RA; Duley L; Egea-Guerrero JJ; England TJ; Karlinski M; Krishnan K; Laska AC; Law ZK; Ovesen C; Ozturk S; Pocock SJ; Roberts I; Robinson TG; Roffe C; Peters N; Scutt P; Thanabalan J; Werring D; Whynes D; Woodhouse L; Bath PM Health Technol Assess; 2019 Jul; 23(35):1-48. PubMed ID: 31322116 [TBL] [Abstract][Full Text] [Related]
10. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Roberts I; Shakur H; Coats T; Hunt B; Balogun E; Barnetson L; Cook L; Kawahara T; Perel P; Prieto-Merino D; Ramos M; Cairns J; Guerriero C Health Technol Assess; 2013 Mar; 17(10):1-79. PubMed ID: 23477634 [TBL] [Abstract][Full Text] [Related]
12. Tranexamic acid for the prevention of postpartum bleeding in women with anaemia: study protocol for an international, randomised, double-blind, placebo-controlled trial. Ker K; Roberts I; Chaudhri R; Fawole B; Beaumont D; Balogun E; Prowse D; Pepple T; Javaid K; Kayani A; Arulkumaran S; Bates I; Shakur-Still H; Trials; 2018 Dec; 19(1):712. PubMed ID: 30594227 [TBL] [Abstract][Full Text] [Related]
13. A nested mechanistic sub-study into the effect of tranexamic acid versus placebo on intracranial haemorrhage and cerebral ischaemia in isolated traumatic brain injury: study protocol for a randomised controlled trial (CRASH-3 Trial Intracranial Bleeding Mechanistic Sub-Study [CRASH-3 IBMS]). Mahmood A; Roberts I; Shakur H Trials; 2017 Jul; 18(1):330. PubMed ID: 28716153 [TBL] [Abstract][Full Text] [Related]
14. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. CRASH-3 trial collaborators Lancet; 2019 Nov; 394(10210):1713-1723. PubMed ID: 31623894 [TBL] [Abstract][Full Text] [Related]
15. Systematic review with meta-analysis: the efficacy of tranexamic acid in upper gastrointestinal bleeding. Twum-Barimah E; Abdelgadir I; Gordon M; Akobeng AK Aliment Pharmacol Ther; 2020 Jun; 51(11):1004-1013. PubMed ID: 32363690 [TBL] [Abstract][Full Text] [Related]
16. Tranexamic acid should be avoided for acute gastrointestinal bleeds. Drug Ther Bull; 2021 Jun; 59(6):84. PubMed ID: 33753352 [No Abstract] [Full Text] [Related]
17. Tranexamic acid to reduce head injury death in people with traumatic brain injury: the CRASH-3 international RCT. Roberts I; Shakur-Still H; Aeron-Thomas A; Beaumont D; Belli A; Brenner A; Cargill M; Chaudhri R; Douglas N; Frimley L; Gilliam C; Geer A; Jamal Z; Jooma R; Mansukhani R; Miners A; Pott J; Prowse D; Shokunbi T; Williams J Health Technol Assess; 2021 Apr; 25(26):1-76. PubMed ID: 33928903 [TBL] [Abstract][Full Text] [Related]
18. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. WOMAN Trial Collaborators Lancet; 2017 May; 389(10084):2105-2116. PubMed ID: 28456509 [TBL] [Abstract][Full Text] [Related]
19. A multi-center, double-blind, placebo-controlled, randomized, parallel-group, non-inferiority study to compare the efficacy of goal-directed tranexamic acid administration based on viscoelastic test versus preemptive tranexamic acid administration on postoperative bleeding in cardiovascular surgery (GDT trial). Nam JS; Oh CS; Kim JY; Choi DK; Oh AR; Park J; Lee JH; Yun SC; Kim KW; Jang MU; Kim TY; Choi IC Trials; 2024 Sep; 25(1):623. PubMed ID: 39334224 [TBL] [Abstract][Full Text] [Related]
20. The effect of tranexamic acid on the risk of death and hysterectomy in women with post-partum haemorrhage: statistical analysis plan for the WOMAN trial. Shakur H; Roberts I; Edwards P; Elbourne D; Alfirevic Z; Ronsmans C Trials; 2016 May; 17(1):249. PubMed ID: 27188698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]